Novo Nordisk receives approval for growth hormone in USA
03-03-2010
09:45
Novo Nordisk announced today that the US Food and Drug Administration, FDA, has approved Norditropin FlexPro, a prefilled growth hormone injection pen, the company wrote today in a press release. The approval concerns growth hormone treatment of both children and adults.
Novo Nordisk introduced Norditropin in 1988, the first liquid growth hormone formulation, Norditropin SimpleXs in 1999, and the first prefilled growth hormone pen, Norditropin NordiFlex in 2004. Direkt/BNS
Novo Nordisk introduced Norditropin in 1988, the first liquid growth hormone formulation, Norditropin SimpleXs in 1999, and the first prefilled growth hormone pen, Norditropin NordiFlex in 2004. Direkt/BNS
*****||*****Novo Nordisk receives approval for growth hormone in USA*****||*****Novo Nordisk announced today that the US Food and Drug Administration, FDA, has approved Norditropin FlexPro, a prefilled growth hormone injection pen, the company wrote today in a press release. The approval concerns growth hormone treatment of both children and adults.*****||*****
Mest læste på borsen.dk
Annonce:
